Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 33
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
2.
Rev Neurol (Paris) ; 135(6-7): 527-40, 1979.
Artigo em Francês | MEDLINE | ID: mdl-531409

RESUMO

The authors report a case of amiodaron-induced neuropathy in a seventy one years old man. First signs appeared seventeen months after the treatment was started with 400 mg/day for one year and continued with 200 mg/day. Examination on the 29th month disclosed a severe sensory and motor deficit of the limbs with distal predominancy. Motor nerve conduction velocity was strongly impaired without modification of distal latencies. Fundi were normal. The patient improved quickly after drug withdrawal. The authors review the rare similar cases reported in the literature and attempt to describe the clinical caracteristics of amiodaron neuropathy. Qualitative and quantitative light and electron microscopical studies of nerve, muscle and skin biopsies, including teased fibers preparations were performed and they disclosed a marked reduction of the number of myelinated fibers. Wallerian degeneration predominated (31 p. 100) other segmental demyalination (25 p. 100). Numerous polymorphous lipid-laden lysosomes were present in Schwann cells, fibrocytes, pericytes, endothelial and muscle cells. These previously undescribed morphological findings are similar to those present in perhexiline maleate intoxications. We believe amiodaron neuropathy is a new neuropathy with drug-induced lipidosis.


Assuntos
Amiodarona/efeitos adversos , Benzofuranos/efeitos adversos , Lipidoses/induzido quimicamente , Doenças do Sistema Nervoso/induzido quimicamente , Idoso , Humanos , Lipidoses/patologia , Lisossomos/ultraestrutura , Masculino , Músculos/patologia , Músculos/ultraestrutura , Nervo Musculocutâneo/patologia , Nervo Musculocutâneo/ultraestrutura , Doenças do Sistema Nervoso/patologia
6.
Nouv Presse Med ; 8(4): 283-92, 1979 Jan 23.
Artigo em Francês | MEDLINE | ID: mdl-122023

RESUMO

The effects of nitroglycerin on systemic vascular resistance and cardiac output are highly debated. This study demonstrates that these effects depend on the initial haemodynamic condition, and explains the conflicting results previously reported. 31 patients presenting initially with a fairly wide spectrum of various haemodynamic parameters underwent cardiac catheterisation with measures of parameters before and after nitroglycerin infusion. Multifactorial statistical analysis by correspondence analysis identifies 3 types of haemodynamic responses and demonstrates the association of each response with a particular haemodynamic profile. It is demonstrated that systemic vascular resistance is decreased only when it is initially elevated and cardiac output is increased only when initial pulmonary wedge pressure and systemic vascular resistance are elevated and cardiac output is low. The effects of nitroglycerin on cardiac output, systemic vascular resistance, heart rate and arterial pressure differ significantly according to the presence or not of cardiac insufficiency and depend mainly on the initial value of three parameters: systemic vascular resistance, pulmonary wedge pressure and cardiac output.


Assuntos
Insuficiência Cardíaca/tratamento farmacológico , Nitroglicerina/uso terapêutico , Adulto , Idoso , Débito Cardíaco/efeitos dos fármacos , Análise Fatorial , Hemodinâmica/efeitos dos fármacos , Humanos , Infusões Parenterais , Pessoa de Meia-Idade , Nitroglicerina/farmacologia , Resistência Vascular/efeitos dos fármacos
12.
Nouv Presse Med ; 6(44): 4119-22, 1977 Dec 24.
Artigo em Francês | MEDLINE | ID: mdl-414205

RESUMO

Seventy four clinically comparable cases of myocardial infarction, admitted on average at the 10th hour were divided at random in two groups: thirty nine were treated with a prolonged intravenous infusion of trinitrin lasting for 24 hours in 12 cases and during 5 at 7 days in 27 cases: 35 served as controls. The results showed the following: a) the good tolerance of the drug used in this way; b) on the basis of precordial cartography, a reduction of 56.2 +/- 14.5% to 30 +/- 7.3% in the index of secondary extension of necrosis; c) clinical signs of left ventricular failure developed in 60% of the controls as compared with 45.8% of the treated group; d) the prevalence of rhythm disturbances was also lower in those treated; e) overall mortality during the first 4 weeks was 8 amongst the 35 controls and 2 of the treated patients (p less than 0.05).


Assuntos
Infarto do Miocárdio/tratamento farmacológico , Nitroglicerina/uso terapêutico , Idoso , Arritmias Cardíacas/etiologia , Pressão Sanguínea/efeitos dos fármacos , Doença das Coronárias/etiologia , Feminino , Insuficiência Cardíaca/etiologia , Frequência Cardíaca/efeitos dos fármacos , Humanos , Infusões Parenterais , Masculino , Pessoa de Meia-Idade , Infarto do Miocárdio/complicações , Infarto do Miocárdio/mortalidade , Infarto do Miocárdio/patologia , Necrose , Nitroglicerina/administração & dosagem , Nitroglicerina/farmacologia , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA